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Lipid droplet (LD) formation is a hallmark of cellular stress. Cells attempt to combat noxious stimuli by switching their metabolism
from oxidative phosphorylation to glycolysis, sparing resources in LDs for generating cellular reducing power and for anabolic
biosynthesis. Membrane phospholipids are also a source of LDs. To elucidate the formation of LDs, we exposed mice to hyperoxia,
hypoxia, myocardial ischemia, and sepsis induced by cecal ligation and puncture (CLP). All the above-mentioned stressors
enhanced the formation of LDs, as assessed by transmission electron microscopy, with severe mitochondrial swelling. Disruption
of mitochondria by depleting mitochondrial DNA (𝜌0 cells) significantly augmented the formation of LDs, causing transcriptional
activation of fatty acid biosynthesis and metabolic reprogramming to glycolysis. Heme oxygenase (HO)-1 counteracts CLP-
mediated septic shock in mouse models. In HO-1-deficient mice, LD formation was not observed upon CLP, but a concomitant
decrease in “LD-decorating proteins” was observed, implying a link between LDs and cytoprotective activity. Collectively, LD
biogenesis during stress can trigger adaptive LD formation, which is dependent on mitochondrial integrity and HO-1 activity;
this may be a cellular survival strategy, apportioning energy-generating substrates to cellular defense.
1. Introduction
Intracellular lipid droplets (LDs) store neutral lipids, includ-
ing triacylglycerol and cholesterol esters, in cells [1]. LDs
are surrounded by a unique phospholipid monolayer that
is decorated with many proteins, among which adipocyte
differentiation-related protein (ADRP) and the perilipin
family are well characterized [2–4]. Although LDs were
initially considered to be static organelles for fat storage,
it is becoming increasingly evident that alterations in the
regulation of formation and breakdown of LD can affect
the risk of metabolic disorders such as diabetes and related
diseases [5–8].
Recently, the biology of LDs has gained public interest
because of the causal link between excess lipid storage in cer-
tain tissues and pathophysiologies related to obesity [9, 10].
In these cases, LDs are likely to interfere with membrane
trafficking of the insulin-sensitive glucose transporter, which
might account for the insulin resistance common in patients
with type 2 diabetes [11].
LDs are formed under two very different environmental
conditions that are not mutually exclusive. First, cells accu-
mulate LDs in response to exogenous lipid availability. It is
thought that the fatty acids in LDs are stored for energy
generation [12], use as membrane building blocks [13], and
biosynthesis of steroid hormones [14]. Second, many kinds of
cellular stress, including inflammation and oxidative stress,
can also induce LD biogenesis [15, 16]. In these cases, it
is hypothesized that fatty acids may serve a protective role
against the stressors.
The underlying molecular mechanisms of fatty acid up-
take and biosynthesis under stress conditions remain largely
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elusive. Ferna`ndez et al. demonstrated that the liver of
caveolin-1-deficient mice fails to store triacylglycerol in LDs
after partial hepatectomy [17]. Caveolin-1 is a structural
protein of plasmalemmal caveolae and has a role in lipid
homeostasis and caveolae-mediated endocytosis [18, 19].
Caveolin-deficient hepatocytes have few LDs and do not
divide for liver regeneration [17]. Administration of glucose
to cav1−/− mice increased survival and caused hepatocytes
to reenter the cell cycle [20]. The above results imply that
caveolin-1 may modulate both lipid metabolism and LD
formation [19], providing survival benefit by assisting liver
regeneration.
Heme oxygenase (HO)-1, an inducible stress protein,
confers cytoprotection against different oxidative stresses in
vitro and in vivo. In addition to its physiological role in
heme degradation, growing evidence demonstrates that HO-
1 can influence a number of cellular processes, including
growth, inflammation, and apoptosis [21–24]. It is generally
accepted that HO-1, a major cytoprotective enzyme, attenu-
ates oxidative stress [25, 26]. Recent observations suggest that
HO-1 may modulate obesity and related metabolic disorders,
implying a metabolic role for the enzyme.
In the current study, we showed that different kinds
of stressors induce LD formation in mouse tissues, with
concomitant upregulation of LD-trafficking proteins. Mito-
chondrial dysfunction may trigger LD biogenesis, which was
not observed in the absence of HO-1 activity. Therefore, LD
appears to mediate the cytoprotective activity of HO-1 under
stress.
2. Materials and Methods
2.1. Animal Oxygen Exposure. Wild-type C57BL/6 mice
(Jackson Laboratories, Bar Harbor, ME, USA), 8–12 weeks
old, were maintained in laminar flow cages in a pathogen-
free facility. All procedures were performed in accordance
with the Council on Animal Care at Harvard University
and the National Research Council’s Guide for the Humane
Care and Use of Laboratory animals. The C57BL/6 mice
were exposed to room air or hyperoxia (95% O
2
, 5% N
2
)
for up to 72 h. Lung tissue was harvested from the mice at
the indicated intervals and used for the biochemical analysis
of autophagy [27]. Wild-type C57BL/6 mice were exposed
to hypoxia (10% O
2
) or normoxia for 3 weeks, and then
their lungs were harvested and analyzed for LD formation by
electron microscopic analysis [28, 29].
Acute myocardial infarction (AMI) was induced in rats
as described previously. In brief, animalswere anesthetized by
intraperitoneal injection of sodiumpentobarbital (50mg/kg),
and AMI was established as described previously [30]. After
implanting the electrocardiogram monitor, the rat was con-
nected to a respirator through tracheotomy, and the heart was
rapidly exteriorized through left thoracotomy and pericardial
incision. The left anterior descending coronary artery was
ligated. Successful establishment of AMI was confirmed by
the pale appearance of the anterior wall of the left ventricular
apex, weakened pulse, and ST-segment elevation. The hearts
were harvested 40 minutes, 24 hours after ligation of the
coronary artery in the AMI group. The rats in the sham-
operated group underwent the same procedure except for the
ligation of the coronary artery.
2.2. Cecal Ligation and Puncture (CLP) Model of Polymi-
crobial Sepsis. The CLP model of polymicrobial sepsis was
performed as previously described [21]. Briefly, anesthesia
was induced in mice by intraperitoneal administration of
100mg/kg ketamine HCl and 43mg/kg xylazine HCl. The
mouse cecum was exposed through a 1.5 cm incision, the
cecum was ligated below the ileocecal valve with a 6–0 silk
suture without causing bowel obstruction, and then, the
cecum was punctured with a 19-gauge needle. A 19-gauge, 1-
hole injury was performed in studies using HO-1-null mice
on a BALB/c background. The cecum was repositioned, and
the abdominal incision was closed in layers with 6–0 surgical
sutures. Sham-operatedmice underwent the same procedure,
including opening of the peritoneum and exposing the bowel,
but without ligation and needle perforation of the cecum.
After surgery, the mice were subcutaneously injected with
1mL of physiological saline for fluid resuscitation. Pre- and
postoperatively, all mice had unlimited access to food and
water.
2.3. Generation of Mitochondrial DNA-(mtDNA-)Deficient
(𝜌0) Cells. A549 cells were from the American Type Culture
Collection (Manassas, VA, USA) and cultured in F12/DMEM
medium (Invitrogen, Carlsbad, CA, USA). The medium
was supplemented with 10% fetal bovine serum (FBS) and
gentamicin. Cells were maintained at 37∘C in humidified
incubators containing an atmosphere of 95% room air and
5% CO
2
. Subconfluent cultures were used in all experiments,
with the cells adhered 24 h before the experiments. A549
lung epithelial cells were grown in F12/DMEM supplemented
with 10% fetal calf serum (FCS), pyruvate (100𝜇g/mL), and
uridine (50𝜇g/mL) as described previously [32]. Ethidium
bromide (EtBr, 100 ng/mL) was also added to the medium for
3 weeks. Depletion of mitochondrial DNA was evaluated by
quantitative real-time PCR as described above [33].
2.4. Electron Microscopy. Cells were fixed in 2.5% glutaralde-
hyde in phosphate-buffered saline (PBS) after experimental
manipulations. The cells were photographed using a JEM
1210 transmission electron microscope (JEOL, Peabody, MA,
USA).
2.5. Western Blot. Western blot analysis for LD-decorating
proteins and transcriptional factors was performed as previ-
ously described [29].
2.6. Statistics. Data are expressed as means ± SEM, and a P
value of <0.05 was considered significant. The significance
of differences between the groups was analyzed with a
Student’s 𝑡-test. Where appropriate, ANOVA with multiple
comparisons followed by a Student’s 𝑡-test was used.
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Figure 1: Enhanced lipid droplet (LD) formation upon hyperoxia in mouse. C57BL/6 mice were exposed to room air (a) or hyperoxia
(95% O
2
, 5% N
2
) (b) for 72 h. Transmission electron microscopy (TEM) images of the lung tissue were captured. The formation of LDs
(white arrowhead) in alveolar type II (ATII) cells increased upon hyperoxic exposure in the mouse lung. A select image in (b) (inset)
was photographed at high power (c). ∗One of the LDs was invaginated by growing lysosomes as reported previously [31]. Bar = 500 nm.
Approximately 50 images were captured from at least 3 individual mice of each group.
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Figure 2: Enhanced LD formation upon hypoxia in mouse. C57BL/6 mice were exposed to room air (a) or hypoxia (10% O
2
, 5% N
2
) (b) for
3 weeks, and the lungs were harvested for further examination by TEM. The formation of LDs (white arrowhead) increased upon hypoxic
exposure in themouse lung epithelial cells. Perinuclear and cytosolic localization of LDs is shown (b). Approximately 50 images were captured
from at least 3 individual mice of each group.
3. Results
To gain insight into the phenotypic alteration of cells by oxy-
genic insults, for which we adopted several model systems.
3.1. Enhanced LD Formation upon Hyperoxia/Hypoxia in
Mouse. First, we examined the response of mouse lungs
under hyperoxic exposure. As shown in Figure 1, the hyper-
oxic stimuli led to an increase in the number of LDs.
Compared with endothelial cells, alveolar type II cells were
more sensitive to high oxygen inhalation in terms of LD
biogenesis (Figures 1(b) and 1(c)). Interestingly, endothelial
mitochondria showed an enlargedmorphology with swelling
compared with those from air-exposed mice (Figure 1(a)).
Chronic hypoxic exposure of mice to 10% oxygen for 3
weeks also increased the number of LDs in alveolar type II
cells (Figures 2(a) and 2(b)). LDs were present close to the
nucleus (Figure 2(b)) and dispersed through the cytosol as
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Figure 3:Myocardial ischemia induces LD formation.TheAMI rat model was established by ligation of the left anterior descending coronary
artery. The hearts were, then, harvested at 40 minutes, 24 hours after ligation in the AMI group. The rats in the sham-operated group
underwent the same procedure except for the ligation of the coronary artery (a). The hearts were examined by TEM. The formation of LDs
was not observed in the heart from 40-minute ligation (subinfarct, (b)) while remarked at 24-hour ligation (white arrowhead, (c) and (d)).
well. Under basal conditions, some LDs also localized near
the nucleus (Figure 2(a)). In addition, autophagosomes were
frequently observed in epithelial cells after hypoxic insult
(Figure 2(b)).
3.2. Myocardial Ischemia Induces LD Formation. Under nor-
mal conditions, only a few small LDs were reported in
mouse hearts [28]. In agreement with this, we found no
detectible LDs under basal conditions in rat heart muscle
(Figure 3(a)). Upon mild ischemic insult, mitochondrial
architecture became irregularly arranged compared with air-
exposed control rats (Figures 3(a) and 3(b)). The heart is
unique in that it cannot fatigue while maintaining life and
it must constantly generate energy in the form of ATP and
phosphocreatine to perform its function. Cardiac muscle
mitochondria are the major energy-producing organelles
that provide working power for muscle contraction. Fatty
acids are the main resources for energy production in
cardiomyocytes [5].Therefore, it is plausible that fatty acids be
segregated in a safe place if the mitochondria were damaged
by ischemic hypoxia. Hypoxia limits the supply of oxygen
available to accept electrons in fatty acid oxidation, which
resulted inmitochondrial injury, as shown in Figures 3(c) and
3(d). Newly formed LDs were mainly present near damaged
mitochondria (Figure 3(d)).
3.3. LD Formation in a Mouse Sepsis Model. Based on recent
observations, treatment ofmacrophageswith lipopolysaccha-
ride (LPS) has been shown to switch cellular metabolism
to glycolysis rather than oxidative phosphorylation. Succi-
nate, an intermediate of the tricarboxylic acid (TCA) cycle,
accumulates relaying signals to trigger an immune reaction
in those cells. In addition, increased hepatic fat storage in
the form of triglycerides is a characteristic feature of sepsis
[15, 16]. In agreement with this notion, our morphological
data also provided evidence that CLP dramatically increased
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Figure 4: LD formation in a sepsismodel inmice. Cecal ligation and puncture (CLP, 19-gauge, 1-hole) was carried out to induce polymicrobial
sepsis in mice. CLP greatly enhances the formation of LDs (arrowhead) in the liver (b) compared with those in sham-operated control mice
(a). To a lesser extent, the kidneys exhibited an increased number of LDs in the epithelial cells (d) comparedwith the control (c). Bar represents
500 nm. Approximately 50 images were captured from at least 3 individual mice of each group.
the number of LDs in the hepatocytes (Figures 4(a) and 4(b)).
Modest increases in the number of LDs in the kidney tissue
were observed, compared with those in the sham-operated
control (Figures 4(c) and 4(d)).
3.4. Loss of mtDNA Increased LD Formation. It is thought
that the conversion of metabolism to glycolysis is a cellular
strategy against various stressors [1]. At the same time,
expression of electron transport chain (ETC) proteins con-
comitantly diminishes. The key proteins involved in the
ETC are mitochondrially translated. Hence, we mimicked
this scenario by depleting mtDNA in A549 cells by treating
them with low doses of EtBr for 3 weeks. The morphological
changes in the mitochondria are shown in Figures 5(b) and
5(c). Most cells stopped growing. At the same time, shrunken
and elongated mitochondria were ubiquitously distributed
throughout the cytosol (black arrow in Figure 5(c)) of A549
𝜌0 cells. Intriguingly, numerous LDs developed in the A549
𝜌0 cells. The expression of PGC-1, a master transcriptional
factor for mitochondria biogenesis, was augmented in the
A549 𝜌0 cells, which probably accounts for a compensatory
mechanism for mtDNA loss in cells. While the expression
of an insulin-sensitive glucose transporter (Glut4) decreased,
that of an insulin-insensitive glucose transporter (Glut1)
slightly increased (Figure 5(d)). To measure metabolic pro-
tein expression, we examined pyruvate kinase M2 (PKM2).
PKM2 favors glycolysis over oxidative phosphorylation for
glucose oxidation. PKM2 expressionwas upregulated inA549
𝜌0 cells. Moreover, the expression of fatty acid synthase (FAS)
was significantly increased inA549𝜌0 cells (Figure 5(e)), sug-
gesting the development of LDs in response to the shortage of
mtDNA.
3.5. Limited LD Formation in the Absence of HO-1 Activity.
Because oxygenic stress and inflammation induce HO-1
and mitochondrial dysfunction triggers LD formation, we
hypothesized that HO-1 activity mediates LD formation
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Figure 5: Paucity of mitochondrial DNA increased LD formation. Cells of a well-characterized human lung carcinoma cell line, A549, were
treated with ethidium bromide (EtBr) for 3 weeks. Petite mitochondria were found in the cytosol of A549 𝜌0 cells ((b), (c), arrow). A549 cells
exhibit normal mitochondrial morphology with organized cristae ((a), arrow). In the vicinity of petite mitochondria, LDs developed ((c),
arrowhead). Bar represents 500 nm. The expression of glucose transporters and PGC-1 was examined with cell lysates of both A549 and 𝜌0
cells (d). The expression of metabolic proteins, PKM1/2 and FAS, was also examined (e). 𝛽-Actin blot serves as a loading control.
in response to mitochondrial defects. As opposed to LD
formation in CLP livers (Figure 4(b)), fewer LDs were
found in the liver of HO-1-deficient mice (Figure 6(b)).
Without CLP, there is no difference in the number of LDs
irrespective of the presence of HO-1 (Figures 4(a) and 6(a)).
In accordance with LD formation in sepsis, the expres-
sion of the LD-decorating proteins, ADRP and perilipin,
was increased compared with HO-1-null livers (Figure 6(c)).
Caveolin-1 expression was also upregulated. Caveolin-1 is a
recently described protein that participates in LD formation
and lipid metabolism. PPAR-𝛾2 modulates LD biogenesis
through SREBP-1 and FAS (Figure 5(e)). The expression of
SREBP-1 was robust in wild-type liver but not in HO-1-null
liver (Figure 6(d)). We validated HO-1 expression in HO-
1-deficient liver (Figure 6(e)). Basal expression of caveolin-
1 was downregulated in the brain of HO-1-null mice, but
it was slightly increased in the liver (Figure 6(e)). Lipid
accumulation and the levels of the nuclear form of SREBP, in
particular subtype 1c, were positively correlated in hydrogen
peroxide-injured hepatocytes. Thus, it has been postulated
that ROSmay stimulate LD formation via SREBP-1 activation
[34].
4. Discussion
In this study, we examined LD formation as a general
response to various stresses in vivo and in vitro. Ample
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Figure 6:Adefect in hepatic LD formation byCLP in hemeoxygenase (HO)-1-deficientmouse. Polymicrobial sepsis was induced as described
in Figure 4 in HO-1-null and control mice. Very few LDs were observed in both wild-type (a) and HO-1-null mice (b). The expression of LD
coat proteins and caveolin-1 was examined (c). FAS levels are generally unaltered in the absence of HO-1 (d). Measurement of basal levels of
caveolin-1 and validation of HO-1-knockout mice were carried out with both cell lysates (e). 𝛽-Actin blot serves as a loading control.
evidence suggests that in response to oxidative stress [35],
organisms can drive theirmetabolic flux fromoxidative phos-
phorylation to glycolysis, including the pentose phosphate
pathway [36], which provides the reducing power for the
maintenance of cellular redox potential. LDbiogenesis during
stress can trigger adaptive LD formation, which depends
on mitochondrial integrity and HO-1 activity; this may be
a cellular survival strategy, apportioning energy-generating
substrates toward cellular defense.
Storage of fatty acids is common to all three domains of
life, including bacteria, archaea, and eukaryotes [37, 38]. The
specialized organelles for fat storage are called lipid bodies,
lipid inclusions, or LDs. These organelles share essentially
the same phenotype, comprising a hydrophobic core of lipids
surrounded by a monolayer of phospholipids.Therefore, LDs
in both worms and mammals, for example, are regarded
as evolutionarily conserved structures that store fatty acids.
Although LD accumulation in fat tissues was once considered
notorious for the obesity-related disorders, LD formation is
actually cytoprotective, since failure to sequester fat into LDs
can cause cellular stress and insulin resistance [5, 34, 37].
Upon exogenous oxygenic insults, organisms protect
themselves by homeostatic modulation of reactive oxygen
species (ROS). One significant source of ROS is generated by
lipid 𝛽-oxidation. FADH
2
generated during the 𝛽-oxidation
of fatty acids enhances the production of ROS via reversing
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the electron flow from electron transport chain complex II to
complex I, amajor source of ROS in themitochondria.There-
fore, the sequestration of fatty acids within LDs, preventing
𝛽-oxidation, is a plausible survival strategy and mechanism
to protect cellular integrity against stress [34].
Insulin reflects an energy surplus, pushing cells to store
the energy as fat and glycogen in insulin-sensitive organs
[39, 40]. At the organism level, however, “transient” insulin
resistance is assumed to be critical in various states such
as starvation, infection, trauma, and even cancer [41–44]
to spare glucose for different biosynthetic purposes, such
as the production of NADPH nucleotides via the pentose
phosphate pathway [36, 40]. Under these conditions, total
glucose oxidation by the TCA cycle is actually low, and energy
demands are primarily met by fatty acid and ketone body
oxidation [40]. In our current study, we aimed to understand
LD formation in response to oxygenic stress and sepsis and to
further reveal the underlying mechanism in mitochondria.
The importance of LDs is nicely exemplified in a liver
regeneration model following partial hepatectomy in mice.
Liver regeneration is an orchestrated cellular response that
coordinates lipid metabolism and cell division. Ferna`ndez
et al. and the Lisanti group demonstrated that caveolin-1-
deficient mice exhibit impaired liver regeneration [17, 19],
thereby resulting in a low survival rate after partial hepa-
tectomy. Reduced LD accumulation in the hepatocytes of
caveolin-1-null mice was responsible for blockade of the
cell cycle, since the infusion of glucose counteracts and
reverses growth arrest. Glucose administration would fulfill
the energetic and biosynthetic intermediate requirements.
This is evidenced by a transient increase in the liver triacyl-
glycerol levels in glucose-fed animals.Therefore, distribution
and allotment of available resources, such as LD biogenesis,
may be a critical factor for wound healing and resistance
against stress. This also implies that LD formation has a
protective role against lipotoxicity derived from free fatty acid
accumulation inside cells. These fatty acids can then be used
for structural functions and additional cellular requirements.
Surprisingly, injured mitochondria are involved in the
formation of LDs under stressed conditions. As expected,
depletion ofmtDNAcausesmorphological changes and alter-
ation of metabolic protein expression. The glucose transport
proteins facilitate glucose transport into insulin-sensitive
cells [39]. Glut1 is insulin independent and is ubiquitously
distributed in different tissues. Glut4 is insulin dependent
and is responsible for the majority of glucose transport into
muscle and adipose cells under anabolic conditions. Park
et al. reported that loss of mitochondrial DNA by chronic
treatment with EtBr downregulates glucose transporters and
reduces intracellular ATP levels in hepatoma cells [45].
They measured protein expression of glucose transporters
and found reduced expression of Glut4. In agreement with
this, A549 𝜌0 cells showed diminished expression of Glut4
(Figure 5(d)), while the expression of Glut1 was slightly
increased (Figure 5(d)). In addition, glycolysis and fatty acid
synthesis may be augmented as assessed by PKM2 and FAS
upregulation (Figure 5(e)). Our results suggest that mtDNA
loss results in metabolic changes resembling the “transient”
insulin-resistant phenotype.
High-yield extraction of ATP from glucose can be
obtained by oxidative phosphorylation [46], but nothing
remains for use as cellular building blocks. Therefore, oxida-
tive phosphorylation is suitable for normal processes in fully
differentiated cells such as neuronal cells. If cells must cope
with adverse situations such as oxidative stress or bacterial
infection [36, 38], the strategy needs to be altered to spare
nutrients for establishing cellular redox status and recovering
damaged cell structures. Glycolysis can be branched out to
the oxidative pentose phosphate pathway, which is a major
source of both reducing power and metabolic intermediates
for biosynthetic processes in cells.
All life on Earth is able to sense oxygen levels in the
environment. Hypoxia, for example, can be managed by
stabilization of hypoxia-inducible factor- (HIF-)1𝛼. HIF-
1𝛼 modulates angiogenesis at the organism level [30] but
switches glucose catabolism to glycolysis at the cellular level.
Both functions are considered homeostatic adjustments to
oxygen. A recent report suggested that hypoxia-inducible
protein 2 (HIG2), which is a downstream target of HIF-1𝛼
transcriptional activity, is implicated in LD biogenesis [35].
HIG2 localizes to LD membranes and coexists with ADRP
and perilipin.Overexpression ofHIG2 is sufficient to increase
in LD accumulation under normal conditions. Our data also
support the idea of accumulation of fatty acids in LDs upon
hypoxia and hyperoxia (Figures 1–3).
If oxidative stress inducesmitochondrial dysfunction, the
organelle sends signals to the nucleus for the recovery of
mitochondria and cellular integrity [47, 48]. We previously
demonstrated that HO-1 activity might be mediated by the
retrograde signal transduction originating from endoplasmic
stresses [23, 26]. In this study, we also have shown that
without HO-1 activity, LD formation in septic liver tissue is
greatly attenuated (Figure 6). In the absence of HO-1 activity,
mice were vulnerable to bacterial infection by CLP, with
increasedmortality rate [21].The role of LDs in the protective
activity of HO-1 in the CLP model and in response to other
stressors warrants further investigation.
Glycolysis is upregulated in some cancer cells. Such shifts
toward a glycolytic phenotype have been explored in other
physiological situations.Themolecularmechanisms underly-
ing these shifts have been focused on the glycolytic enzymes
such as muscle-type phosphofructokinase or pyruvate kinase
M. On the other hand, mitochondrial inhibition of ATP
synthesis could also act as a trigger for the initiation of
glycolysis via ATPase inhibitory factor- (IF-)1. Thus, mul-
tiple pathways are operating to switch cellular metabolism
under stressed conditions. ATP production appears to be
significantly reduced by the inhibition of heme biosynthesis
with succinylacetone (SA), since ATPase IF-1 expression was
remarkably augmented by SA (data not shown). Diminished
ATP production resulted in mitochondrial dysfunction and
switching to glycolysis for glucose catabolism [46]. Heme
proteins that mainly operate in the ETC would be degraded
by the heme catabolic enzyme HO-1. In this context, it has
been reported that carbon monoxide, a byproduct of HO-1
activity, relays retrograde signals in neuronal systems [48].
Therefore, the role of HO-1 activity in linking mitochondrial
dysfunction to LD biogenesis warrants further study.
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Collectively, mitochondrial dysfunction may trigger LD
formation by switching metabolic pathways to glycolysis and
fatty acid biosynthesis. During this process, HO-1 activity
appears necessary to form LDs through upregulation of
proteins for LD trafficking and lipid metabolism.
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